UX-GIP001 cell therapy for drug-resistant temporal lobe epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a new cell therapy, UX-GIP001, for people whose seizures start in one small area of the brain (the mesial temporal lobe) and are not controlled by at least two seizure medications. The goal is to see if this treatment can safely reduce seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your seizures start from one specific area deep inside the temporal lobe (mesial temporal lobe epilepsy).
- You have tried at least two seizure medications at high enough doses, but seizures still happen.
- You have had at least 4 focal (partial) seizures per month on average over the past 3 months.
- You have been on the same doses of your seizure meds for at least the last month.
- You have no other major health problems (such as a severe immune disorder or recent cancer) and do not have metal implants in your skull or brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell-based treatment for people with epilepsy that has not improved with standard medications. The treatment aims to reduce seizures in patients with a specific type of epilepsy originating from one side of the brain.
This trial tests a brain stimulation treatment for people with temporal lobe epilepsy that doesn't improve with medication. The goal is to see if it can reduce seizures.
This trial tests a minimally invasive brain surgery that targets a small area deep in the brain to stop seizures in people whose epilepsy has not improved with medications. It may help reduce or eliminate seizures caused by scarring in the temporal lobe.
This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This study tests a new way to treat seizures that start in the temporal lobe using special electrical signals that focus on the seizure area without surgery. It may help reduce seizures in people whose seizures don't stop with medicine.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.